Clinical Trial Update: Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

View source ↗

Summary

This clinical trial update concerns antimicrobial therapy for difficult-to-treat Pseudomonas aeruginosa infections. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Aeruginosa Infection
• Pseudomonas Infections

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: Pseudomonas Infections, Pseudomonas Aeruginosa | Status: RECRUITING